Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 23 September 2026, detailing a fresh share buyback executed on the same day.
The company repurchased 198,000 ordinary shares on the open market at prices between HKD 0.775 and HKD 0.815 per share, at a volume-weighted average of HKD 0.80. The aggregate consideration amounted to HKD 0.16 million.
Following the transaction, Dingdang Health’s outstanding shares (excluding treasury stock) declined by 0.02% to 1.24 billion, while treasury shares increased to 5.03 million. Total issued shares remain unchanged at 1.24 billion.
The repurchase forms part of the mandate approved on 23 June 2026, which authorises the company to buy back up to 124.32 million shares. Including this latest transaction, cumulative repurchases under the mandate stand at 7.89 million shares, equivalent to 0.63% of the shares outstanding on the mandate date.
All 198,000 shares acquired on 23 September are being held as treasury shares; none have been cancelled. Under Hong Kong listing rules, Dingdang Health is subject to a moratorium on issuing new shares or selling treasury shares until 23 October 2026.
Comments